AMERIPRISE FINANCIAL INC - SAGENT PHARMACEUTICALS INC ownership

SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103. A total of 134 filers reported holding SAGENT PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
AMERIPRISE FINANCIAL INC ownership history of SAGENT PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2016$6,485,000
+375.1%
432,937
+286.1%
0.00%
+300.0%
Q1 2016$1,365,000
-22.0%
112,137
+1.9%
0.00%0.0%
Q4 2015$1,751,000
+1.7%
110,059
-2.0%
0.00%0.0%
Q3 2015$1,721,000
-33.9%
112,252
+4.7%
0.00%0.0%
Q2 2015$2,605,000
+6.4%
107,175
+1.8%
0.00%0.0%
Q1 2015$2,448,000
-2.7%
105,258
+5.1%
0.00%0.0%
Q4 2014$2,515,000
-18.0%
100,164
+1.5%
0.00%
-50.0%
Q3 2014$3,068,000
+14509.5%
98,670
+9387.5%
0.00%
Q3 2013$21,000
-4.5%
1,0400.0%0.00%
Q2 2013$22,0001,0400.00%
Other shareholders
SAGENT PHARMACEUTICALS INC shareholders Q4 2015
NameSharesValueWeighting ↓
Timpani Capital Management LLC 110,215$2,248,0001.32%
Healthcare Value Capital, LLC 73,822$1,506,0001.32%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,014,863$20,703,0000.96%
Perimeter Capital Partners, LLC 248,893$5,077,0000.94%
Tekla Capital Management LLC 270,031$5,509,0000.61%
SECTORAL ASSET MANAGEMENT INC 564,325$11,512,0000.55%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 168,268$3,432,0000.35%
MENTA CAPITAL LLC 30,480$622,0000.32%
KOPP INVESTMENT ADVISORS LLC 39,934$815,0000.30%
Broadfin Capital, LLC 68,300$1,393,0000.25%
View complete list of SAGENT PHARMACEUTICALS INC shareholders